| ADL | Activities of Daily Living |
| AEs | Adverse Events |
| AMT | Thermoresponsive hydrogel formulation (AMT-143) |
| APIs | Active Pharmaceutical Ingredients |
| BCL | Bandage Contact Lens |
| DDS | Drug Delivery System(s) |
| EHO | Experimental Hydrogel with Olea europaea extract (EHO-85) |
| ENT | Ear, Nose, and Throat |
| HA | Hyaluronic Acid |
| LD | Lidocaine |
| NO | Nitric Oxide |
| NRS | Numerical Rating Scale |
| NSAIDs | Non-Steroidal Anti-Inflammatory Drugs |
| OA | Osteoarthritis |
| PF | Poloxamer Formulation (e.g., PF72 hydrogel) |
| PK | Pharmacokinetics |
| PRISMA-ScR | Preferred Reporting Items for Systematic Reviews and Meta-Analyses—Scoping Review extension |
| PRK | Photorefractive Keratectomy |
| RCT | Randomized Controlled Trial |
| RCTs | Randomized Controlled Trials |
| TA | Triamcinolone Acetonide |
| TLA | Topical Local Anesthetic |
| VAS | Visual Analog Scale |